These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 513216)

  • 1. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF; Wright GL; Rosato FE; Faulconer RJ
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some uses and limitations of immunologic testing in human patients.
    Lavergne JA
    Bol Asoc Med P R; 1981 Apr; 73(4):141-5. PubMed ID: 6946780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the cellular immune response in patients with urinary bladder carcinoma. IV. Leukocyte adherence inhibition tests and leukocyte migration inhibition test (author's transl)].
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Maekawa M
    Nihon Hinyokika Gakkai Zasshi; 1979 Mar; 70(3):305-16. PubMed ID: 374815
    [No Abstract]   [Full Text] [Related]  

  • 7. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.
    Pizza G; Viza D; Fini M; Cuzzocrea D; Menniti D; Corrado F
    Eur Urol; 1980; 6(1):45-7. PubMed ID: 7353578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro production of a transfer factor specific for transitional-cell carcinoma of the bladder.
    Pizza G; Viza D; Boucheix C; Corrado F
    Br J Cancer; 1976 Jun; 33(6):606-11. PubMed ID: 938610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukocyte adherence inhibition assay as a measure of antitumor immunity in bladder cancer patients.
    Ramsey EW; Malcolm AJ
    J Urol; 1981 Nov; 126(5):600-3. PubMed ID: 7029006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery].
    Borisenko ID; Novikov DK; Shein IA
    Urol Nefrol (Mosk); 1978; (2):26-9. PubMed ID: 644715
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity.
    Lee VK; Harriott TG; Kuchroo VK; Halliday WJ; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6286-90. PubMed ID: 3875859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro migration inhibition of leukocytes from cancer patients by extracts of autologous and homologous tumors].
    Novikov DK; Adamenko GP
    Dokl Akad Nauk SSSR; 1974; 217(3):715-8. PubMed ID: 4848926
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
    Bubeník J
    Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the immune response to the organ-specific neoantigen of human bladder cancer.
    Lajzerowicz M; Thomson DM; Reid EC
    J Urol; 1982 Nov; 128(5):1122-9. PubMed ID: 6960193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antigenic differences and similarities between human transitional cell carcinoma cell lines using rabbit antisera.
    Bloom ET; Brown DE
    Urol Res; 1980; 8(1):5-13. PubMed ID: 6154368
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic evaluation of human bladder cancer: in vitro studies.
    Elhilali MM; Nayak SK
    Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of transitional cell bladder cancer antigen on established cell lines.
    Boxer RJ; Sofen H; Saxon A
    Invest Urol; 1981 Sep; 19(2):70-4. PubMed ID: 7024183
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer].
    Xu JN; Li YT; Zhang ZY
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):453-6, 508. PubMed ID: 4092537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.